702 related articles for article (PubMed ID: 14562125)
41. Bone marrow minimal disseminated disease (MDD) and minimal residual disease (MRD) in childhood T-cell lymphoblastic lymphoma stage III, detected by flow cytometry (FC) and real-time quantitative polymerase chain reaction (RQ-PCR).
Stark B; Avigad S; Luria D; Manor S; Reshef-Ronen T; Avrahami G; Yaniv I
Pediatr Blood Cancer; 2009 Jan; 52(1):20-5. PubMed ID: 19006253
[TBL] [Abstract][Full Text] [Related]
42. Multiplex reverse transcription-polymerase chain reaction as diagnostic molecular screening of 4 common fusion chimeric genes in Taiwanese children with acute lymphoblastic leukemia.
Yang YL; Lin SR; Chen JS; Hsiao CC; Lin KH; Sheen JM; Cheng CN; Wu KH; Lin SW; Yu SL; Chen HY; Lu MY; Chang HH; Yen CT; Lin JF; Su YH; Li YP; Lin CY; Jou ST; Lin DT
J Pediatr Hematol Oncol; 2010 Nov; 32(8):e323-30. PubMed ID: 20930648
[TBL] [Abstract][Full Text] [Related]
43. Combined use of reverse transcriptase polymerase chain reaction and flow cytometry to study minimal residual disease in Philadelphia positive acute lymphoblastic leukemia.
Muñoz L; López O; Martino R; Brunet S; Bellido M; Rubiol E; Sierra J; Nomdedéu JF
Haematologica; 2000 Jul; 85(7):704-10. PubMed ID: 10897122
[TBL] [Abstract][Full Text] [Related]
44. [Quantification of PML/RAR alpha fusion gene transcripts in patients with acute promyelocytic leukemia by using real-time quantitative PCR].
Lin J; Han LX; Qian J; Wang YL; Qian Z; Yang XF; Sheng XJ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):319-21. PubMed ID: 18543226
[TBL] [Abstract][Full Text] [Related]
45. Preclinical validation of a monochrome real-time multiplex assay for translocations in childhood acute lymphoblastic leukemia.
Siraj AK; Ozbek U; Sazawal S; Sirma S; Timson G; Al-Nasser A; Bhargava M; El Solh H; Bhatia K; Gutiérrez MI
Clin Cancer Res; 2002 Dec; 8(12):3832-40. PubMed ID: 12473597
[TBL] [Abstract][Full Text] [Related]
46. Comparison of bone marrow high mitotic index metaphase fluorescence in situ hybridization to peripheral blood and bone marrow real time quantitative polymerase chain reaction on the International Scale for detecting residual disease in chronic myeloid leukemia.
Lundán T; Juvonen V; Mueller MC; Mustjoki S; Lakkala T; Kairisto V; Hochhaus A; Knuutila S; Porkka K
Haematologica; 2008 Feb; 93(2):178-85. PubMed ID: 18223279
[TBL] [Abstract][Full Text] [Related]
47. Rapid screening of leukemia fusion transcripts in acute leukemia by real-time PCR.
Osumi K; Fukui T; Kiyoi H; Kasai M; Kodera Y; Kudo K; Kato K; Matsuyama T; Naito K; Tanimoto M; Hirai H; Saito H; Ohno R; Naoe T
Leuk Lymphoma; 2002 Dec; 43(12):2291-9. PubMed ID: 12613515
[TBL] [Abstract][Full Text] [Related]
48. Monitoring of minimal residual disease by quantitative WT1 gene expression following reduced intensity conditioning allogeneic stem cell transplantation in acute myeloid leukemia.
Candoni A; Toffoletti E; Gallina R; Simeone E; Chiozzotto M; Volpetti S; Fanin R
Clin Transplant; 2011; 25(2):308-16. PubMed ID: 20412098
[TBL] [Abstract][Full Text] [Related]
49. Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia.
Nakao M; Yokota S; Horiike S; Taniwaki M; Kashima K; Sonoda Y; Koizumi S; Takaue Y; Matsushita T; Fujimoto T; Misawa S
Leukemia; 1996 Sep; 10(9):1463-70. PubMed ID: 8751464
[TBL] [Abstract][Full Text] [Related]
50. Comparison of minimal residual disease (MRD) estimated by flow cytometry and by real-time quantitative PCR of Wilms tumor gene 1 (WT1) transcript expression in children with acute lymphoblastic leukemia.
Chen JS; Hsiao CC; Sheen JM; Cheng CN
Leuk Res; 2007 Oct; 31(10):1351-7. PubMed ID: 17445885
[TBL] [Abstract][Full Text] [Related]
51. Differential stability of control gene and fusion gene transcripts over time may hamper accurate quantification of minimal residual disease--a study within the Europe Against Cancer Program.
van der Velden VH; Boeckx N; Gonzalez M; Malec M; Barbany G; Lion T; Gottardi E; Pallisgaard N; Beillard E; Hop WC; Hoogeveen PG; Gabert J; van Dongen JJ;
Leukemia; 2004 Apr; 18(4):884-6. PubMed ID: 14961029
[No Abstract] [Full Text] [Related]
52. [Determination of the common molecular markers in newly diagnosed leukemias by using real-time quantitative RT-PCR].
Yao L; Chen ZX; Cen JN; Qiu QC; He J; Bao XJ; Yuan XN
Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):192-5. PubMed ID: 18788621
[TBL] [Abstract][Full Text] [Related]
53. Methylated RASSF1a is the first specific DNA marker for minimal residual disease testing in neuroblastoma.
Stutterheim J; Ichou FA; den Ouden E; Versteeg R; Caron HN; Tytgat GA; van der Schoot CE
Clin Cancer Res; 2012 Feb; 18(3):808-14. PubMed ID: 22142825
[TBL] [Abstract][Full Text] [Related]
54. TEL/AML 1 real-time quantitative reverse transcriptase PCR can complement minimal residual disease assessment in childhood ALL.
Fronkova E; Madzo J; Zuna J; Reznickova L; Muzikova K; Hrusak O; Stary J; Trka J
Leukemia; 2005 Jul; 19(7):1296-7. PubMed ID: 15858617
[No Abstract] [Full Text] [Related]
55. Monitoring minimal residual disease in leukemia using real-time quantitative polymerase chain reaction for Wilms tumor gene (WT1).
Tamaki H; Mishima M; Kawakami M; Tsuboi A; Kim EH; Hosen N; Ikegame K; Murakami M; Fujioka T; Masuda T; Taniguchi Y; Nishida S; Osumi K; Soma T; Oji Y; Oka Y; Kawase I; Sugiyama H; Ogawa H
Int J Hematol; 2003 Nov; 78(4):349-56. PubMed ID: 14686494
[TBL] [Abstract][Full Text] [Related]
56. Molecular methods used for detection of minimal residual disease following hematopoietic stem cell transplantation in myeloid disorders.
Elmaagacli AH
Methods Mol Biol; 2014; 1109():187-207. PubMed ID: 24473785
[TBL] [Abstract][Full Text] [Related]
57. [Study on the analytical error factors and evaluation of an internal control gene for leukemia gene expression analysis].
Satoh Y; Yokota H; Takai D; Yatomi Y
Rinsho Byori; 2012 Aug; 60(8):740-7. PubMed ID: 23198532
[TBL] [Abstract][Full Text] [Related]
58. Characterization of a reference material for BCR-ABL (M-BCR) mRNA quantitation by real-time amplification assays: towards new standards for gene expression measurements.
Saldanha J; Silvy M; Beaufils N; Arlinghaus R; Barbany G; Branford S; Cayuela JM; Cazzaniga G; Gonzalez M; Grimwade D; Kairisto V; Miyamura K; Lawler M; Lion T; Macintyre E; Mahon FX; Muller MC; Ostergaard M; Pfeifer H; Saglio G; Sawyers C; Spinelli O; van der Velden VH; Wang JQ; Zoi K; Patel V; Phillips P; Matejtschuk P; Gabert J
Leukemia; 2007 Jul; 21(7):1481-7. PubMed ID: 17476280
[TBL] [Abstract][Full Text] [Related]
59. [Detection of MRD and its clinical application--review].
Zhu YM; Chen SJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1131-6. PubMed ID: 16403298
[TBL] [Abstract][Full Text] [Related]
60. [The current status of genetic testing for leukemia].
Satoh Y; Masuda A; Yokota H; Yatomi Y
Rinsho Byori; 2014 Apr; 62(4):369-77. PubMed ID: 25022066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
